Abstract
The metabolism of leukotrienes is central to their effective operation as lipid mediators. Covalent modification of leukotriene structures results largely in reduced or terminated biological activity, thus making metabolism a major process limiting leukotriene action in vivo. The majority of the enzymatic pathways involved in metabolic processing are common to a host of other endogenous biochemical substances, in particular eicosanoids such as prostaglandins and thromboxanes. However, there are several enzymes rather specific for certain leukotrienes, suggesting a more unique role for such metabolic events mediated by these enzymes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lam BK, Gagnon L, Austen KF, Soberman RJ (1990) The mechanims of leukotriene B4 export from human polymorphonuclear leukocytes. J Biol Chem 265: 13438–13441
Marleau S, Dallaire N, Poubelle PE, Borgeat P (1994) Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits. Br J Pharmacol 112: 654–658
Leier I, Muller M, Jedlitschky G, Keppler D (1992) Leukotriene uptake by hepatocytes and hepatoma cells. Eur J Biochem 209: 281–289
Lindgren JA, Hansson G, Samuelsson B (1981) Formation of novel hydroxylated eicosatetraenoic acids in preparations of human polymorphonuclear leukocytes. FEBS Lett 128: 329–335
Shak S, Goldstein IM (1985) Leukotriene B4 ω-hydroxylase in human polymorphonu-clear leukocytes: Partial purification and identification as a cytochrome P450. J Clin Invest 76: 1218–1228
Harper TW, Garrity MJ, Murphy RC (1986) Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite. J Biol Chem 261: 5414–5418
Newton JF, Eckardt R, Bender PE, Leonard T, Straub K (1985) Metabolism of leukotriene B4 in hepatic microsomes. Biochem Biophys Res Commun 128: 733–738
Hansson G, Lindgren JA, Dahlen SE, Hedqvist P, Samuelsson B (1981) Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett 130: 107–112
Clancy RM, Dahinden CA, Hugli TE (1984) Oxidation of leukotrienes at the co end: Demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc Natl Acad Sci USA 81: 5729–5733
Okita JR, Castle PJ, Okita RT (1993) Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J Biochem Toxicol 8: 135–144
Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii-Kuriyama Y, Kusunose M (1993) A novel form of cytochrome P-450 family in human polymorphonuclear leukocytes: cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 268: 9376–9380
Chen L, Hardwick JP (1993) Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors. Arch Biochem Biophys 300: 18–23
Kawashima H, Kusunose E, Thompson CM, Strobel HW (1997) Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch Biochem Biophys 347: 148–154
Kikuta Y, Kusunose E, Kondo T, Yamamoto S, Kinoshita H, Kusunose M (1994) Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett 348: 70–74
Soberman RJ, Sutyak JP, Okita RT, Wendelborn DF, Roberts LJ, Austen KF (1988) The identification and formation of 20-aldehyde leukotriene B4. J Biol Chem 263: 7996–8002
Schluter B, Schonfeld W, Konig W (1988) Generation and metabolism of leukotrienes and release of histamine from human dispersed tonsillar cells. Scand J Immunol 27: 451–459
Schonfeld W, Schluter R, Hilger R, Konig (1988) Leukotriene generation and metabolism in isolated human lung macrophages. Immunol 65: 529–536
Gotoh Y, Sumimoto H, Takeshige K, Minakami S, Keppler D (1988) NADtdependent oxidation of 20-hydroxyleukotriene B4 to 20-carboxyleukotriene B4 by rat liver cytosol. Biochim Biophys Acta 960: 342–350
Baumert T, Huber M, Mayer D, Keppler D (1989) Ethanol-induced inhibition of leukotriene degradation by omega-oxidation. Eur J Biochem 182: 223–229
Shirley MA, Murphy RC (1992) Novel 3-hydroxylated leukotriene B4 metabolites from ethanol-treated rat hepatocytes. J Am Soc Mass Spectrom 3: 762–768
Sumimoto H, Minakami S (1990) Oxidation of 20-hydroxyleukotriene B4 to 20-carboxyleukotriene B4 by human neutrophil microsomes. Role of aldehyde dehydrogenase and leukotriene B4 w-hydroxylase (cytochrome P-450LTBω) in leukotriene B4 cu-oxidation. J Biol Chem 265: 4348–4353
Hankin JA, Clay CE, Murphy RC (1998): The effects of ethanol and acetaldehyde on the metabolism of prostaglandin E2 and leukotriene B4 in isolated rat hepatocytes. J Pharmacol Exp Ther 285: 155–161
Powell WS (1987) Conversion of leukotriene B4 to dihydro and 19-hydroxy metabolites by rat polymorphonuclear leukocytes. Biochem Biophys Res Commun 145: 991–998
Powell WS, Gravelle F (1989) Metabolism of leukotriene B4 to dihydro and dihydro-oxo products by porcine leukocytes. J Biol Chem 264: 5364–5369
Wainwright SL, Powell WS (1991) Mechanism for the formation of dihydro metabolites of 12-hydroxyeicosanoids: Conversion of leukotriene B4 and 12-hydroxy-5,8,10,14eicosatetraenoic acid to 12-oxo intermediates. J Biol Chem 266: 20899–20906
Yokomizo T, Izumi T, Takahashi T, Kasama T, Kobayashi Y, Sato F, Taketani Y, Shimizu T (1993) Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase. J Biol Chem 268: 18128–18135
Powell WS, Rokach J, Khanapure SP, Manna S, Hashefi M, Gravel S, MacLeod RJ, Falck JR, Bhatt RK (1996) Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels. J Pharm Exp Ther 276: 728–236
Kaever V, Damerau B, Wessel K, Resch K (1988) Biological properties of dihydro-leukotriene B4, an alternative leukotriene B4 metabolite. FEBS Lett 231: 385–388
Yokomizo T, Ogawa Y, Uozumi N, Kume K, Izumi T, Shimizu T (1996) cDNA cloning, expression, and mutagenesis study of leukotriene B4 12-hydroxydehydrogenase. J Biol Chem 271: 2844–2850
Ensor CM, Zhang H, Tai HH (1998) Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochem J 330: 103–108
Romano MC, Eckardt RD, Bender PE, Leonard TB, Straub KM, Newton JF (1987) Biochemical characterization of hepatic microsomal leukotriene B4 hydroxylases. J Biol Chem 262: 1590–1595
Jedlitschky G, Huber M, Volkl A, Muller M, Leier I, Muller J, Lehmann WD, Fahimi HD, Keppler D (1991) Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end. J Biol Chem 266: 24763–24772
Shirley MA, Murphy RC (1990) Metabolism of leukotriene B4 in isolated rat hepatocytes. Involvement of 2,4-dienoyl-coenzyme A reductase in leukotriene B4 metabolism. J Biol Chem 265: 16288–16295
Powell WS (1986) Novel pathway for the metabolism of 6-trans-leukotriene B4 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 136: 707–712
Powell WS, Gravelle F (1988) Metabolism of 6-trans isomers of leukotriene B4 to dihydro products by human polymorphonuclear leukocytes. J Biol Chem 263: 2170–2177
Wheelan P, Murphy RC (1995) Metabolism of 6-trans isomers of leukotriene B4 in cultured hepatoma cells and in human polymorphonuclear leukocytes: Identification of a δ6-reductase metabolic pathway. J Biol Chem 270: 19845–19852
Tokumoto H, Watanabe K, Fukushima D, Shimiza T, Hayaishi O (1982) An NADP-linked 15-hydroxyprostaglandin dehydrogenase specific for prostaglandin D2 from swine brain. J Biol Chem 257: 13576–13580
Wheelan P, Zirrolli JA, Morelli JG, Murphy RC (1993) Metabolism of leukotriene B4 by cultured human keratinocytes. Formation of glutathione conjugates and dihydro metabolites. J Biol Chem 268: 25439–25448
Armstrong RN (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10: 2–18
Guhlmann A, Krauss K, Oberdorfer F, Siegel T, Scheuber PH, Muller J, Csuk-Glanzer B, Ziegler S, Ostertag H, Keppler D (1995) Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography. Hepatology 21: 1568–1575
Orning L, Hammarstrom S, Samuelsson B (1980) Leukotriene D: A slow reacting sub-stance from rat basophilic leukemia cells. Proc Natl Acad Sci USA 77: 2014–2017
Bernstrom K, Hammarstrom S (1981) Metabolism of leukotriene D by porcine kidney. J Biol Chem 256: 9579–9582
Keppler D, Guhlmann A, Huber M (1990) Metabolism and actions of leukotrienes in vivo. Prog Appl Microcirc 17: 129–141
Raulf M, Stuning M, Konig W (1985) Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology 55: 135–147
Yokota K, Shono F, Yamamoto S, Kominami E, Katunuma N (1983) Transformation of leukotriene Dq catalyzed by lysosomal cathepsin H of rat liver. J Biochem 94: 1173–1178
Orning L, Norin E, Gustafsson B, Hammarstrom S (1986) In vivo metabolism of leukotriene Cq in germ-free and conventional rats: Fecal excretion of N-acetyl leukotriene E4. J Biol Chem 261: 766–771
Hagmann W, Denzlinger C, Rapp S, Weckbecker G, Keppler D (1986) Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Prostaglandins 31: 239–251
Sala A, Voelkel N, Maclouf J, Murphy RC (1990) Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem 265: 21771–21778
Stene DO, Murphy RC (1988) Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes. J Biol Chem 263: 2773–2778
Orning L (1987) ω-Oxidation of cysteine-containing leukotrienes by rat-liver microsomes: Isolation and characterization of ω-hydroxy and ω-carboxy metabolites of leukotriene E4 and N-acetyl leukotriene E4. Eur J Biochem 170: 77–85
Keppler D, Huber M, Baumert T, Guhlmann A (1989) Metabolic inactivation of leukotrienes. In: G Weber (ed): Advances in enzyme regulation. Pergamon Press, New York, 307–319
Maclouf J, Antoine C, De Caterina R, Sicari R, Murphy RC, Patrignani P, Loizzo S, Patrono C (1992) Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. Am J Physiol 263: H244–H249
Sala A, Voelkel N, Maclouf J, Murphy RC (1990) Metabolism of radioisotopic variants of LTE4 in human subjects and excretion of urinary metabolites. Adv Prostaglandin Thromboxane Leukot Res 21A: 177–180
Murphy RC, Sala A, Voelkel N, Maclouf J (1991) Appearance of urinary metabolites of LTE4 in human subjects. Ann NY Acad Sci 629: 105–111
Kumlin M, Sven-Erik D (1990) Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochim Biophys Acta 1044: 201–210
Fauler J, Marx K-H, Kaever V, Frolich JC (1989) Human monocytes convert leukotriene Bq to two dihydro-leukotriene B4-metabolites. Prostaglandins Leukot Essent Fatty Acids 37: 193–196
Serafin WE, Oates JA, Hubbard WC (1983) Metabolism of leukotriene B4 in the monkey. Identification of the principal nonvolatile metabolite in the urine. Prostaglandins 27: 899–911
Mathews WR, Guido DM, Taylor BM, Sun FF (1993) Metabolism of leukotriene B4 by guinea pig eosinophils. Prostaglandins 45: 347–361
Kasimir S, Schonfeld W, Hilger RA, Konig W (1991) Analysis of leukotriene B4 metabolism in human promyelocytic HL-60 cells. Biochem J 279: 283–288
Kaever V, Bruuns J, Wunder J, Damerau B, Zimmer G, Fauler J (1990) Human glomerular mesangial cells inactivate leukotriene B4 by reduction into dihydro-leukotriene B4 metabolites. Life Sci 46: 1465–1470
Kaever V (1987) A novel metabolic pathway for leukotriene B4 in different cell types: primary reduction of double bond. Biochim Biophys Acta 922: 337–344
Wainwright S, Falck JR, Yadagiri P, Powell WS (1990) Stereochemistry of leukotriene B4 metabolites formed by the reductase pathway in porcine polymorphonuclear leukocytes: Inversion of stereochemistry of the 12-hydroxyl group. Biochem 29: 1180–1185
Wheelan P, Murphy RC (1995) Metabolism of leukotriene B4 in cultured hepatoma cells. Arch Biochem Biophys 321: 381–389
Wheelan P, Simon FR, Murphy RC (1996) GC/MS analysis of oxo and chain-shortened leukotriene B4 metabolites: Leukotriene B4 metabolism in Ito cells. J Mass Spectrom 31: 236–246
Hirata K, Maghni K, Borgeat P, Sirois P (1990) Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene. J Immunol 144: 1880–1885
Maas RL, Brash AR, Oates JA (1982) Novel leukotrienes and lipoxygenase products from arachidonic acid. In: B Samuelsson, R Paoletti (eds): Leukotrienes and other lipoxygenase products. Raven Press, New York, 29–44
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Murphy, R.C., Hankin, J.A. (1999). Metabolism of leukotrienes and formation of new leukotriene structures. In: Folco, G., Samuelsson, B., Murphy, R.C. (eds) Novel Inhibitors of Leukotrienes. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8703-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8703-8_4
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9736-5
Online ISBN: 978-3-0348-8703-8
eBook Packages: Springer Book Archive